TY  - GEN
AU  - Voskaridou,Ersi
AU  - Terpos,Evangelos
AU  - Spina,Giovanna
AU  - Palermos,John
AU  - Rahemtulla,Amin
AU  - Loutradi,Aphroditi
AU  - Loukopoulos,Dimitris
TI  - Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia
SN  - 0007-1048
PY  - 2004///0105
KW  - Acid Phosphatase
KW  - blood
KW  - Adult
KW  - Alkaline Phosphatase
KW  - Anti-Inflammatory Agents
KW  - administration & dosage
KW  - Biomarkers
KW  - Blood Transfusion
KW  - Bone Density
KW  - drug effects
KW  - Carrier Proteins
KW  - Case-Control Studies
KW  - Collagen
KW  - urine
KW  - Collagen Type I
KW  - Diphosphonates
KW  - Drug Administration Schedule
KW  - Female
KW  - Glycoproteins
KW  - Humans
KW  - Isoenzymes
KW  - Lumbar Vertebrae
KW  - Male
KW  - Membrane Glycoproteins
KW  - Middle Aged
KW  - Osteocalcin
KW  - Osteoporosis
KW  - drug therapy
KW  - Osteoprotegerin
KW  - Pamidronate
KW  - Peptides
KW  - RANK Ligand
KW  - Receptor Activator of Nuclear Factor-kappa B
KW  - Receptors, Cytoplasmic and Nuclear
KW  - Receptors, Tumor Necrosis Factor
KW  - Statistics, Nonparametric
KW  - Tartrate-Resistant Acid Phosphatase
KW  - beta-Thalassemia
KW  - complications
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1046/j.1365-2141.2003.04657.x
ER  -